VIDEO: BDO’s Aftab Jamil Discusses Significant Changes in Life Sciences Financing

Aftab Jamil of BDO spoke with OneMedTV during the 6th Annual OneMedForum in January to discuss the state of life sciences investment, and how companies can formulate new strategies to attract a sustainable class of investors. At the core of these new strategies are the initiatives being implemented to increase access to non-venture capital in the earlier rounds, which may incubate a company long enough to grow a pipeline, attract tenable/diverse revenue opportunity, and eventually reach market.

Read more »

BIOTECH 2012: Panel of CEOs — Lather, Rinse, Repeat

Hosted by BioNJ, Pennsylvania Bio and Delaware Bio, their three word mission: “Find. Fund. Facilitate.” was clearly accomplished. Networking is still an integral part of these cerebral gatherings, however programming at this conference provided attendees with candid information, stimulating conversation and a new perspective on the industry.

Read more »

FDA’s Farm Animal Antibiotics Ban Ignored Since 1977, Courts Say

The Food and Drug Administration must act quickly to enforce a largely ignored 35-year-old mandate prohibiting non-medical use of antibiotics in farm animals.

Read more »

A Comparison Between European and U.S. Venture Capital Industries

According to an article in the Independent (UK), 84 percent of participants at a recent biotech conference in Monaco cited “funding” as the biotechnology industry’s biggest challenge.

Read more »